{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T07:49:58Z","timestamp":1793432998940,"version":"4.5.0"},"reference-count":52,"publisher":"American Physiological Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Physiology-Renal Physiology"],"published-print":{"date-parts":[[2008,2]]},"abstract":"<jats:p> The progressive deterioration of renal function and structure resulting from renal mass reduction are mediated by a variety of mechanisms, including oxidative stress and inflammation. Melatonin, the major product of the pineal gland, has potent_antioxidant and anti-inflammatory properties, and its production is impaired in chronic renal failure. We therefore investigated if melatonin treatment would modify the course of chronic renal failure in the remnant kidney model. We studied rats followed 12 wk after renal ablation untreated (Nx group, n = 7) and treated with melatonin administered in the drinking water (10 mg\/100 ml) (Nx + MEL group, n = 8). Sham-operated rats ( n = 10) were used as controls. Melatonin administration increased 13\u201315 times the endogenous hormone levels. Rats in the Nx + MEL group had reduced oxidative stress (malondialdehyde levels in plasma and in the remnant kidney as well as nitrotyrosine renal abundance) and renal inflammation (p65 nuclear factor-\u03baB-positive renal interstitial cells and infiltration of lymphocytes and macrophages). Collagen, \u03b1-smooth muscle actin, and transforming growth factor-\u03b2 renal abundance were all increased in the remnant kidney of the untreated rats and were reduced significantly by melatonin treatment. Deterioration of renal function (plasma creatinine and proteinuria) and structure (glomerulosclerosis and tubulointerstitial damage) resulting from renal ablation were ameliorated significantly with melatonin treatment. In conclusion, melatonin administration improves the course of chronic renal failure in rats with renal mass reduction. Further studies are necessary to define the potential usefulness of this treatment in other animal models and in patients with chronic renal disease. <\/jats:p>","DOI":"10.1152\/ajprenal.00500.2007","type":"journal-article","created":{"date-parts":[[2007,12,12]],"date-time":"2007-12-12T20:45:17Z","timestamp":1197492317000},"page":"F336-F344","source":"Crossref","is-referenced-by-count":75,"title":["Melatonin ameliorates oxidative stress, inflammation, proteinuria, and progression of renal damage in rats with renal mass reduction"],"prefix":"10.1152","volume":"294","author":[{"given":"Yasmir","family":"Quiroz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atilio","family":"Ferrebuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddy","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nosratola D.","family":"Vaziri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Rodriguez-Iturbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"24","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1080\/08860220701391738"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00192.2002"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/30.7.881"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199701163360306"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1385\/ENDO:27:2:189"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-007-0242-1"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1007\/s004670050591"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(01)80124-4"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1097\/00041552-200311000-00004"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00600.x"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1111\/j.0894-0959.2004.17605.x"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1994.tb56826.x"},{"key":"R13","unstructured":"Karasek M, Szuflet A, Chrzanowski W, Zylinska K, Swietolawski J. Circadian serum melatonin profiles in patients suffering from chronic renal failure. Neuro Endocrinol Lett 23, Suppl 1: 97\u2013102, 2002."},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1097\/00041552-200009000-00004"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.2007.00459.x"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1159\/000086411"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2005.05.002"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-142-1-200501040-00110"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2004.04.007"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00385.2002"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.2000.279.5.F910"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(79)90738-3"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2042.2007.01806.x"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2003.02188.x"},{"key":"R25","unstructured":"Poeggeler B, Saarela S, Reiter RJ, Tan DX, Chen LD, Manchester LC, Barlow-Warden LR. Melatonin: a highly potent endogenous radical scavenger and electron donor: new aspects of the oxidation chemistry of this indole accessed in vitro. Ann NY Acad Sci 17: 419\u2013129, 1994."},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.2001.281.1.F38"},{"key":"R27","doi-asserted-by":"crossref","unstructured":"Reiter RJ, Calvo JR, Kerbownik M, Qi W, Tan DX. Melatonin and its relation to the immune system and inflammation. Ann NY Acad Sci 917: 376\u2013386, 2000.","DOI":"10.1111\/j.1749-6632.2000.tb05402.x"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.2005.00261.x"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1007\/BF02253360"},{"key":"R30","unstructured":"Reiter RJ, Tan DX, Pilar Terron M, Flores LJ, Czarnocki Z. Melatonin and its metabolites: new findings regarding their production and their radical scavenging actions. Acta Biochim Pol 54: 1\u20139, 2007."},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.088062"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.0590051626.x"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.00737.x"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.0197.2001"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1159\/000082313"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2005.7.1269"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.055003945.x"},{"key":"R38","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-079X.2002.01858.x"},{"key":"R39","unstructured":"Sewerynek E, Reiter RJ, Melchierri D, Ortiz GG, Lewinski A. Oxidative damage in liver induced by ischemia-reperfusion: protection by melatonin. Hepatogastroenterology 43: 898\u2013905, 1996."},{"key":"R40","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00260.2006"},{"key":"R41","unstructured":"Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ. Melatonin: a potent endogenous hydroxyl radical scavenger. Endocr J 1: 57\u201360, 1993."},{"key":"R42","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2007.07.005"},{"key":"R43","doi-asserted-by":"publisher","DOI":"10.1159\/000190144"},{"key":"R44","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.107.123638"},{"key":"R45","unstructured":"Vaziri ND, Rodriguez-Iturbe B. Mechanisms of disease: oxidative stress and inflammation in the patogenesis of hypertension Nature. CP Nephrol 2: 582\u2013593, 2006."},{"key":"R46","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00099.2005"},{"key":"R47","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2004.06.026"},{"key":"R48","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00702.x"},{"key":"R49","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1998.00947.x"},{"key":"R50","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1996.361"},{"key":"R51","unstructured":"Vaziri ND, Oveisi F, Wierszbiezki M, Shaw V, Sporty LD. Serum melatonin and 6-sulphatoxymelatonin in end-stage renal disease: Effect of hemodialysis. Artif Organs 17: 764\u2013769, 1993."},{"key":"R52","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002019"}],"container-title":["American Journal of Physiology-Renal Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.physiology.org\/doi\/pdf\/10.1152\/ajprenal.00500.2007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,8]],"date-time":"2019-09-08T18:39:31Z","timestamp":1567967971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.physiology.org\/doi\/10.1152\/ajprenal.00500.2007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["10.1152\/ajprenal.00500.2007"],"URL":"https:\/\/doi.org\/10.1152\/ajprenal.00500.2007","relation":{},"ISSN":["1931-857X","1522-1466"],"issn-type":[{"value":"1931-857X","type":"print"},{"value":"1522-1466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}